After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Medical Devices industry segment. The current market capitalization of Pacific Biosciences of California Inc is $315.09M. A total of 5.64 million shares were traded on the day, compared to an average of 8.85M shares.
In the most recent transaction, Farmer Michele sold 5,195 shares of PACB for 1.00 per share on May 19 ’25. After the transaction, the insider now owns 269,259 company shares. In a previous transaction on Mar 03 ’25, HENRY CHRISTIAN O sold 12,497 shares at 1.41 per share. PACB shares that the insider owns now total 2,225,357.
Among the insiders who sold shares, Van Oene Mark disposed of 6,486 shares on Mar 03 ’25 at a per-share price of $1.41. This resulted in the insider holding 1,497,695 shares of PACB after the transaction. In another insider transaction, Farmer Michele sold 2,973 shares at $1.41 per share on Mar 03 ’25. Company shares held by the insider now total 184,619.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, PACB has a high of $2.72 and a low of $0.85.
As of this writing, PACB has an earnings estimate of -$0.16 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of -$0.14 per share and a lower estimate of -$0.18.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. PACB’s latest balance sheet shows that the firm has $1.04B in Cash & Short Term Investments as of fiscal 2021. There were $955.36M in debt and $71.71M in liabilities at the time. Its Book Value Per Share was $0.31, while its Total Shareholder’s Equity was $790.99M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PACB is Buy with a score of 3.86.
